Genxone Spolka Akcyjna Logo

Genxone Spolka Akcyjna

A biotechnology company specializing in Next Generation Sequencing and medical diagnostics.

GX1 | WAR

Overview

Corporate Details

ISIN(s):
PLGENXN00013
LEI:
25940043REFNZY18T558
Country:
Poland
Address:
SUCHY LAS ZŁOTNIKI, KOBALTOWA 6, 62-002 SUCHY LAS

Description

Genxone is a biotechnology company that develops products and solutions based on advanced nucleic acid technologies. The company specializes in Next Generation Sequencing (NGS) and medical diagnostics, offering a range of DNA and RNA sequencing services. It is a pioneer in the application of nanopore sequencing technology, developed by Oxford Nanopore Technologies, being one of the first laboratories globally to utilize it for commercial applications in science, business, and medicine. Key services include whole-genome sequencing, metagenomic sequencing, 16S/ITS gene sequencing, custom-designed analyses, and comprehensive bioinformatic support.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-08 14:25
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
Polish 1.2 KB
2024-03-06 16:41
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
Polish 1.8 KB
2023-11-16 15:32
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
Polish 1.1 KB
2023-11-14 14:32
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
Polish 1.7 KB
2023-10-23 16:34
Aktualizacja informacji na temat umowy warunkowej o istotnym znaczeniu - Conten…
Polish 948 bytes
2023-07-20 15:09
Zawarcie istotnej umowy - Content (PL)
Polish 1.0 KB
2023-06-19 15:31
Lista akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 470 bytes
2023-05-22 15:37
Sprawozdanie RN genXone za 2022 rok
Polish 991.6 KB
2023-05-22 15:37
Projekty uchwał WZA genXone SA
Polish 284.6 KB
2023-05-22 15:37
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki genXone SA
Polish 291.5 KB
2023-05-22 15:37
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki genXone S.A. na d…
Polish 6.6 KB
2023-05-09 15:57
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
Polish 857 bytes
2023-05-05 16:54
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
Polish 1.5 KB
2023-04-26 17:03
Aktualizacja informacji na temat prac badawczych w ramach projektu NANOBIOME - …
Polish 1.7 KB
2023-03-21 08:05
Zawiadomienia_o_transakcjach_osoby_zobowiazanej_Jakub_Swadzba_20230320.pdf
Polish 9.7 KB

Automate Your Workflow. Get a real-time feed of all Genxone Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genxone Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genxone Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CAMBRIDGE COGNITION HOLDINGS PLC Logo
Develops digital solutions and a platform for CNS clinical trials to assess brain health.
United Kingdom
COG
A clinical-stage biopharmaceutical company developing novel cancer therapeutics.
Japan
4575
Captor Therapeutics S.A. Logo
Develops Targeted Protein Degradation therapies for cancer and autoimmune diseases.
Poland
CTX
Cardiff Oncology, Inc. Logo
A clinical-stage biotech developing cancer therapies that inhibit Polo-like kinase 1.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
Develops AI-powered epigenetic and genetic tests for early heart disease detection.
United States of America
CDIO
CASSAVA SCIENCES INC Logo
Clinical-stage biotech developing treatments for Central Nervous System disorders.
United States of America
SAVA
Celcuity Inc. Logo
Clinical-stage biotech developing targeted therapies for multiple solid tumors.
United States of America
CELC
Develops and manufactures cellulose-based nonwoven fabrics for the cosmetics sector.
South Korea
318160
CEL SCI CORP Logo
Clinical-stage biotech developing immunotherapies for cancer and infectious diseases.
United States of America
CVM
Celyad Oncology SA Logo
Biotechnology company developing innovative CAR-T cell therapies to treat cancer.
Belgium
CYAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.